Page last updated: 2024-11-02

oxidopamine and Palsy

oxidopamine has been researched along with Palsy in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guido, W1
Salinger, WL1

Other Studies

1 other study available for oxidopamine and Palsy

ArticleYear
6-Hydroxydopamine treatment blocks the effects of chronic monocular paralysis in the cat's lateral geniculate nucleus.
    Brain research, 1989, Nov-06, Volume: 501, Issue:2

    Topics: Animals; Cats; Functional Laterality; Geniculate Bodies; Hydroxydopamines; Neuronal Plasticity; Oxid

1989